LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 201 filers reported holding LEGEND BIOTECH CORP in Q3 2023. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,487,527 | -2.7% | 1,123,828 | +0.0% | 9.13% | +0.5% |
| Q2 2023 | $77,568,459 | +23.1% | 1,123,692 | -14.0% | 9.09% | +44.6% |
| Q1 2023 | $63,007,531 | +7.7% | 1,306,668 | +11.5% | 6.29% | -9.1% |
| Q4 2022 | $58,494,659 | -2.2% | 1,171,768 | -20.1% | 6.91% | -20.5% |
| Q3 2022 | $59,831,000 | -11.0% | 1,466,453 | +20.0% | 8.69% | -9.9% |
| Q2 2022 | $67,229,000 | +68.1% | 1,222,342 | +11.1% | 9.65% | +74.2% |
| Q1 2022 | $39,994,000 | -14.6% | 1,100,542 | +9.5% | 5.54% | +13.3% |
| Q4 2021 | $46,831,000 | -31.7% | 1,004,742 | -25.9% | 4.89% | +17.6% |
| Q3 2021 | $68,587,000 | +24.5% | 1,356,542 | +1.1% | 4.16% | +81.3% |
| Q2 2021 | $55,107,000 | +80.1% | 1,342,442 | +27.3% | 2.29% | +79.5% |
| Q1 2021 | $30,594,000 | +40.1% | 1,054,242 | +36.0% | 1.28% | +10.0% |
| Q4 2020 | $21,831,000 | -27.0% | 775,242 | -20.0% | 1.16% | -42.3% |
| Q3 2020 | $29,909,000 | -41.4% | 968,862 | -19.2% | 2.02% | -49.2% |
| Q2 2020 | $51,007,000 | – | 1,198,483 | – | 3.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |